December 30, 2020: We strongly oppose the approval of this modified risk application for six Camel Snus smokeless tobacco products. If Camel Snus are declared to be a MRTP, there is a risk of increased use of these products, due to perceptions of safety as well as the appeal of flavored products.
Read More »Tag: tobacco
NCHR’s Comments on USPSTF’s Draft Recommendation Statement for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
We strongly agree with the USPSTF’s recommendation that all physicians ask their adult patients and pregnant patients about their tobacco use. However, encourage the USPSTF to consider two suggestions that would strengthen this recommendation.
Read More »NCHR’s Comments on FDA’s Notice on the Modified Risk Tobacco Product Applications for IQOS System With Marlboro Heatsticks
February 24, 2020. We oppose the modified labeling of Marlboro Heatsticks. This change may lead non-smokers, particularly adolescents, to begin using tobacco products.
Read More »NCHR Testimony on Low Nicotine Cigarette Claim
February 14, 2020. NCHR strongly opposes the approval of this modified risk application by the 22nd Century Group for their low-nicotine combusted filtered cigarette tobacco products. Evidence is lacking to support the claim that this product significantly reduces harm for smokers. At the same time, it is likely to entice people who have never smoked, especially adolescents, to start smoking.
Read More »NCHR Comments on FDA’s Notice on the Modified Risk Tobacco Product Application for Copenhagen Snuff Fine Cut
January 21, 2020. We strongly oppose the approval of the modified risk application for Copenhagen Snuff Fine Cut with the claim “IF YOU SMOKE, CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer.” This claim may encourage non-smokers to begin using tobacco. Using smokeless tobacco increases the risk of serious health issues.
Read More »